SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K405 - Annual report [Sections 13 and 15(d), S-K Item 405]:
SEC Accession No. 0000950135-97-001385
Filing Date
1997-03-28
Accepted
1997-03-28 00:00:00
Documents
7
Period of Report
1996-12-31
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 FORM 10-K405 10-K405 230430
2 FIRST AMENDMENT TO RIGHTS AGREEMENT EX-4.3 7751
3 1996 STOCK & OPTION PLAN EX-10.3 41391
4 SECOND AMENDMENT TO LEASE EX-10.14 3765
5 FIRST AMENDMENT TO LEASE AGREEMENT EX-10.16 1675
6 CONSENT OF INDEPENDENT PUBLIC ACCOUNTANTS EX-23 909
7 FINANCIAL DATA SCHEDULE EX-27 2151
  Complete submission text file 0000950135-97-001385.txt   290060
Mailing Address
Business Address 130 WAVERLY STREET CAMBRIDGE MA 02139-4242 6165776000
VERTEX PHARMACEUTICALS INC / MA (Filer) CIK: 0000875320 (see all company filings)

IRS No.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-K405 | Act: 34 | File No.: 000-19319 | Film No.: 97566016
SIC: 2834 Pharmaceutical Preparations